Effects of inhibitors of protein and nucleic acid synthesis on the expression of H-2 and Moloney leukemia virus-determined cell-surface antigens on cultured murine lymphoma cells.
D000818:Animals; D000941:Antigens; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002462:Cell Membrane / Q000276:immunology*; D002478:Cells, Cultured; D003470:Culture Media; D003513:Cycloheximide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D006649:Histocompatibility Antigens; D006918:Hydroxyurea / Q000494:pharmacology; D008223:Lymphoma / Q000276:immunology*; D051379:Mice; D008937:Mitomycins / Q000494:pharmacology; D008979:Moloney murine leukemia virus / Q000276:immunology*; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009374:Neoplasms, Experimental / Q000276:immunology; D011691:Puromycin / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis
D000941:Antigens; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D000970:Antineoplastic Agents; D003470:Culture Media; D006649:Histocompatibility Antigens; D008937:Mitomycins; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D003561:Cytarabine; D003609:Dactinomycin; D011691:Puromycin; D003513:Cycloheximide; D006918:Hydroxyurea